BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 35757700)

  • 1. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.
    Wiech M; Chroscicki P; Swatler J; Stepnik D; De Biasi S; Hampel M; Brewinska-Olchowik M; Maliszewska A; Sklinda K; Durlik M; Wierzba W; Cossarizza A; Piwocka K
    Front Immunol; 2022; 13():886431. PubMed ID: 35757700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.
    Kudryavtsev IV; Arsentieva NA; Korobova ZR; Isakov DV; Rubinstein AA; Batsunov OK; Khamitova IV; Kuznetsova RN; Savin TV; Akisheva TV; Stanevich OV; Lebedeva AA; Vorobyov EA; Vorobyova SV; Kulikov AN; Sharapova MA; Pevtsov DE; Totolian AA
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions.
    Siemińska I; Węglarczyk K; Surmiak M; Kurowska-Baran D; Sanak M; Siedlar M; Baran J
    Front Immunol; 2021; 12():748097. PubMed ID: 34659245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
    Ryan FJ; Hope CM; Masavuli MG; Lynn MA; Mekonnen ZA; Yeow AEL; Garcia-Valtanen P; Al-Delfi Z; Gummow J; Ferguson C; O'Connor S; Reddi BAJ; Hissaria P; Shaw D; Kok-Lim C; Gleadle JM; Beard MR; Barry SC; Grubor-Bauk B; Lynn DJ
    BMC Med; 2022 Jan; 20(1):26. PubMed ID: 35027067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity.
    Li Y; Wang X; Shen XR; Geng R; Xie N; Han JF; Zhang QM; Shi ZL; Zhou P
    Emerg Microbes Infect; 2022 Dec; 11(1):902-913. PubMed ID: 35240947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives.
    Torres Rives B; Zúñiga Rosales Y; Mataran Valdés M; Roblejo Balbuena H; Martínez Téllez G; Rodríguez Pérez J; Caridad Marín Padrón L; Rodríguez Pelier C; Sotomayor Lugo F; Valdés Zayas A; Carmenate Portilla T; Sánchez Ramírez B; Carlos Silva Aycaguer L; Portal Miranda JA; Marcheco Teruel B
    Immunobiology; 2022 May; 227(3):152216. PubMed ID: 35436751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity.
    Berentschot JC; Drexhage HA; Aynekulu Mersha DG; Wijkhuijs AJM; GeurtsvanKessel CH; Koopmans MPG; Voermans JJC; Hendriks RW; Nagtzaam NMA; de Bie M; Heijenbrok-Kal MH; Bek LM; Ribbers GM; van den Berg-Emons RJG; Aerts JGJV; Dik WA; Hellemons ME
    Front Immunol; 2023; 14():1254899. PubMed ID: 37881427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein.
    Visvabharathy L; Hanson BA; Orban ZS; Lim PH; Palacio NM; Jimenez M; Clark JR; Graham EL; Liotta EM; Tachas G; Penaloza-MacMaster P; Koralnik IJ
    Front Immunol; 2023; 14():1155770. PubMed ID: 37313412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.
    Gurevich M; Zilkha-Falb R; Sonis P; Magalashvili D; Menascu S; Flechter S; Dolev M; Mandel M; Achiron A
    Int J Infect Dis; 2022 Feb; 115():208-214. PubMed ID: 34896265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent CD8
    LaVergne SM; Dutt TS; McFann K; Baxter BA; Webb TL; Berry K; Tipton M; Stromberg S; Sullivan BM; Dunn J; Henao-Tamayo M; Ryan EP
    Front Immunol; 2023; 14():1303971. PubMed ID: 38327763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA.
    Mazzitelli M; Trunfio M; Sasset L; Leoni D; Castelli E; Lo Menzo S; Gardin S; Putaggio C; Brundu M; Garzotto P; Cattelan AM
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of memory T cell subsets and common γ-chain cytokines in convalescent COVID-19 individuals.
    Rajamanickam A; Pavan Kumar N; Pandiaraj AN; Selvaraj N; Munisankar S; Renji RM; Venkataramani V; Murhekar M; Thangaraj JWV; Muthusamy SK; Chethrapilly Purushothaman GK; Bhatnagar T; Ponnaiah M; Ramasamy S; Velusamy S; Babu S
    J Leukoc Biol; 2022 Jul; 112(1):201-212. PubMed ID: 35258122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell responses in COVID-19 survivors 6-8 months after infection: A longitudinal cohort study in Pune.
    Suryawanshi P; Patil-Takbhate B; Athavale P; Mirza S; Tripathy A; Kanitkar S; Shivnitwar S; Barthwal MS; Dole S; Chavan H; Jali P; Pawale S; Kakad D; Kakrani AL; Bhawalkar J; Gandhi M; Chaturvedi S; Karandikar M; Tripathy S
    Immun Inflamm Dis; 2024 Jun; 12(6):e1238. PubMed ID: 38860770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status.
    Gatti A; Zizzo G; De Paschale M; Tamburello A; Castelnovo L; Faggioli PM; Clerici P; Brando B; Mazzone A
    PLoS One; 2023; 18(5):e0285728. PubMed ID: 37220145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Frequencies of Phenotypically and Functionally Senescent and Exhausted CD56
    Srivastava R; Dhanushkodi N; Prakash S; Coulon PG; Vahed H; Zayou L; Quadiri A; BenMohamed L
    bioRxiv; 2022 Jul; ():. PubMed ID: 35923316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome.
    Hackenbruch C; Maringer Y; Tegeler CM; Walz JS; Nelde A; Heitmann JS
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
    Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
    Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1-Expressing SARS-CoV-2-Specific CD8
    Rha MS; Jeong HW; Ko JH; Choi SJ; Seo IH; Lee JS; Sa M; Kim AR; Joo EJ; Ahn JY; Kim JH; Song KH; Kim ES; Oh DH; Ahn MY; Choi HK; Jeon JH; Choi JP; Kim HB; Kim YK; Park SH; Choi WS; Choi JY; Peck KR; Shin EC
    Immunity; 2021 Jan; 54(1):44-52.e3. PubMed ID: 33338412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired adaptive immune response in COVID-19 convalescent patients with hematological malignancies.
    Kalicińska E; Szymczak D; Andrasiak I; Milanowska A; Kiraga A; Majeranowski A; Jabłonowska P; Rybka J; Maciej Z; Wróbel T
    Eur J Haematol; 2023 Apr; 110(4):396-406. PubMed ID: 36562254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.